Cosmo Pharmaceuticals N.V.
CMOPF
Price:
$64.37
Market Cap:
$1.01B
Cosmo Pharmaceuticals N.V., a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesavancol and UCERIS/Cortiment, an oral tablet formulation for remission in active, mild to moderate ulcerative colitis; GI Genius, a system that uses artificial intelligence to detect colorectal polyps; and Methylene Blue MMX, diagnostic drug to enhance pre-cancerous and cancerous detection of colorectal lesions during colonoscopy. The company also provides Eleview, an injectable composition for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancer...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2017-07-31
Stock Exchange
OTC
Ticker
CMOPF
PE Ratio
[6.95]
ROE
[13.96%]
Current Ratio
[4.19]
Dividend Yield
[6.04%]
Enterprise Value
[965.96M]
Dividend History
CMOPF Dividend History Overview
Dividends are a key part of long-term returns for investors, and Cosmo Pharmaceuticals N.V. (CMOPF) has a track record worth reviewing. Looking at dividend history for CMOPF gives you an idea of how consistent the dividends have been and what you might expect in the future.
Ex-Dividend Date
2025-06-04
Dividend Yield
6.04%
Annual Dividend
$2.22
P/E Ratio
6.95
Payout Ratio
0.06
Dividend per Share
$3.80
EPS
9.26
| Ex-Date/EFF Date | Dividend Amount | Adjusted Dividend | Payment Date | Declaration Date |
|---|---|---|---|---|
| 2025-06-04 | $2.2175 | $2.34313 | 2025-06-06 | 2025-03-06 |
| 2024-07-10 | $2.16316 | $2.16316 | 2024-07-12 | |
| 2023-05-31 | $1.05 | $1.05 | 2023-06-02 | |
| 2022-06-01 | $0.95 | $0.95 | 2022-06-03 | |
| 2017-05-29 | $1.67655 | $1.67655 | 2017-05-31 |
Cosmo Pharmaceuticals N.V. (CMOPF) Dividend History Chart
The table below shows Cosmo Pharmaceuticals N.V. (CMOPF) dividend history over the years, including the amount per share, the payout date, and any adjustments for stock splits.
Cosmo Pharmaceuticals N.V. (CMOPF) Dividend Growth
Cosmo Pharmaceuticals N.V. (CMOPF) dividend history also allows you to track its dividend growth over time. This gives you insight into how the company’s earnings and payout ratios have evolved. Tracking this growth can help you gauge the stock's potential for future income.
Other Popular Dividend Stocks
Check out the dividend history of other popular stocks:
| Stock name | Dividend yield |
|---|---|
| Johnson & Johnson (JNJ) | 0.03% |
| AbbVie Inc. (ABBV) | 0.03% |
| Eli Lilly and Company (LLY) | 0.01% |
| Merck & Co., Inc. (MRK) | 0.04% |
| Bristol-Myers Squibb Company (BMY) | 0.05% |
Track & Identify Dividend Stocks
Tracking and finding valuable dividend stocks to invest in is difficult. For this, you can use Wisesheets, which allows you to pull all necessary dividend, financial, and price data to track your dividend investments in one place exactly how you want, using the power of spreadsheets.
You can build any custom analysis dashboards, screeners and trackers with no code and analyze companies like Cosmo Pharmaceuticals N.V. (CMOPF) without the pain and hassle of copy pasting data.
Frequently asked questions❓
What is dividend history?
How do I check past dividend history?
What does the ex-dividend date mean?
What is CMOPF’s dividend yield?
What is the difference between regular and special dividends?
Has CMOPF increased its dividends over time?
Why might dividend history data be delayed?
How often does CMOPF pay dividends?
What factors impact CMOPF's dividend payments?
Can dividends change over time?
What is CMOPF’s next dividend date?